Wound-Healing Product Jurisdiction To Be Challenged At June FDA Hearing

FDA is considering whether to reassign primary jurisdiction of certain tissue-based products, such as interactive wound dressings, to the Center for Biologics Evaluation & Research

More from Archive

More from Medtech Insight